Txcell

Developer of personalized immunotherapies for chronic inflammatory diseases

placeValbonne, Provence Alpes Cote D Azur, France calendar_todayFounded 2001 groups45 employees language txcell.com

Innovation

23 patent families (14 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 1,143 times.

YearFilings
20127
201311
20148
20159
201610
20177
20183
20191

Investor mix

10 investors on record.

Investor typeCountShare
Venture capital330%
Private equity110%
Bank & private debt110%
Other / undisclosed550%
Coming soon